Compare Cytokinetics Inc (CYTK) vs Diageo plc (DEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Diageo plc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Diageo plc trades at $94.54 (market cap $53.05B). The key difference: Diageo plc is far larger — about 5× Cytokinetics Inc's market cap, and Diageo plc pays a 3.5% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | DEO | |
|---|---|---|
Market Cap | $10.63B | $53.05B |
Sector | Technology | Technology |
52-Week High | $87.26 | $115.33 |
52-Week Low | $34.31 | $72.47 |
Enterprise Value | $10.74B | $72.54B |
Dividend Yield | — | 3.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →
